Ambagon Therapeutics is developing a new class of medicines that can modulate previously undruggable targets and influence currently accessible ones in new ways, focusing on 14-3-3 proteins and their role in various diseases
Ambagon Therapeutics is developing a new class of medicines that can modulate previously undruggable targets and influence currently accessible ones in new ways, focusing on 14-3-3 proteins and their role in various diseases.